Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
POLICY PAPERS
October 04, 2022
In this paper, we report the results of a horizon-scanning exercise to source opportunities for global health R&D investment—that is, high-value potential biomedical innovations which are currently underfunded but which could be transformative for health, quality of life, and health security in LMIC...
Blog Post
September 15, 2022
Countries in Latin America were hit especially hard by the COVID-19 pandemic. On this episode of Pandemic Proof, Amanda Glassman welcomes Dr. Jarbas Barbosa da Silva Jr., candidate for Director of the Pan American Health Organization (PAHO), to the podcast to discuss impacts and lessons learned. Tog...
WORKING PAPERS
September 06, 2022
Can governments contract out school management at scale? In 2016 the Government of Punjab transferred management of over 4,000 failing primary schools to private operators. Schools remained free to students. Private operators received a government subsidy per enrolled student of less than half per-s...
Blog Post
July 20, 2022
Get ready for Pandemic Proof, a new podcast from the Center for Global Development. Hosted by CGD's Amanda Glassman and Javier Guzman and featuring guests from around the world, Pandemic Proof will confront weaknesses in the global architecture for pandemic preparedness and response, and explore pol...
Blog Post
June 10, 2022
In June 2021, Dr. Tedros Ghebreyesus, offered a challenge to the world: “To truly end the pandemic, our goal must be to vaccinate at least 70 percent of the world’s population by the time you meet again in Germany next year.” However, as we approach this year’s G7 summit, the 70 percent target has b...
Blog Post
May 26, 2022
Yesterday at the annual World Health Assembly in Geneva, member states passed a resolution tabled by the Argentina, Peru, and the UK that aims to strengthen clinical trials to improve public health. As COVID-19 has made abundantly clear, the evidence generated by high-quality clinical trials is esse...
CGD NOTES
May 11, 2022
This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks.